G.V. Anand Bhushan, then Partner at Shardul Amarchand Mangaldas & Co., provided expert commentary in this article published by Express Pharma.
The article analysed the pharmaceutical sector's growing vulnerability to cyber-attacks and the critical importance of building cyber resilience. Bhushan provided expert commentary on the legal and regulatory implications for pharma companies, including compliance requirements, intellectual property protection, and the need for sector-specific cybersecurity frameworks to protect sensitive research and patient data.
Read Original Article →